DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Myriad Genetics Sees Q3 Adj. EPS $0.02 vs $0.30 Estimate, Sales $172M vs $201M Est.; FY20 Adj. EPS $0.45 vs $1.06 Est., Sales $735M vs $807M Est.

Benzinga · 02/06/2020 21:21